지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Rectal cancer
대한임상종양학회 학술대회지
2011 .05
Managements for T1-2 Rectal Cancer
대한임상종양학회 학술대회지
2014 .03
암색전의 맥관 내 맥관 형성에 관한 면역조직화학적 연구
Journal of Pathology and Translational Medicine
2007 .01
Rectal perforation by compressed air
Annals of Surgical Treatment and Research
2017 .07
Experience of sexual life in men with rectal cancer
성인간호학회 학술대회
2016 .06
Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
Radiation oncology journal : ROJ
2016 .01
Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer
Radiation oncology journal : ROJ
2012 .01
[4]직장의 건강사정
대한간호
1977 .01
소아 직장암 1예
Annals of Surgical Treatment and Research
1997 .04
Robotic Rectal Cancer Surgery
대한임상종양학회 학술대회지
2016 .02
Risk Factors for Developing Large Emboli Following Carotid Artery Stenting
대한신경외과학회지
2013 .01
Locally Advanced Rectal Cancer
대한임상종양학회 학술대회지
2014 .03
Landmark trials for rectal cancer
대한외과학회 학술대회 초록집
2014 .11
Risk Assessment on Anastomotic Leakage after Rectal Cancer Surgery: An Analysis of 753 Patients
Asian Pacific journal of cancer prevention : APJCP
2013 .01
Long-term Clinical Outcomes and Risk of Peritoneal Seeding after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Focus on Perforation during the Procedure
Gut and Liver
2019 .01
중 하부 직장암의 수술적 치료에 대한 종양학적 고찰
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2012 .06
자궁경부암 환자의 고선량률 강내치료 시행 시 직장합병증의 예측
Radiation oncology journal : ROJ
2003 .01
Intestinal Perforation in Colorectal Cancers Treated with Bevacizumab (Avastin®)
Cancer Research and Treatment
2008 .01
Rectal: Fluorescence-guided Lateral Pelvic Lymphadenectomy in Rectal Cancer
대한임상종양학회 학술대회지
2018 .02
Does total regression of primary rectal cancer after preoperative chemoradiotherapy represent “no tumor” status?
Annals of Surgical Treatment and Research
2019 .02
0